Gara Jalqabaatti › Histiyosaayitoosis Seli Laangerhaans › New York

Qorannoo klinikaalii Histiyosaayitoosis Seli Laangerhaans New York keessatti

Qorannoo 3 Histiyosaayitoosis Seli Laangerhaans f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

New York CityQorannoo 3

Takkalaa qorannoo (Ingiliffa)

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
fi 7 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

180 Days – 22 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05828069

Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ama-2026 · NCT03329274

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin hundi · Saalaa hunda · Haaromfame 18-Ful-2025 · NCT04079179

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.